Interscapular Region Research Articles

Antimicrobial Activity of Artemisia absinthium Against Surgical Wounds Infected by Staphylococcus aureus in a Rat Model

The wound infection is one of the frequent complications in patients undergoing surgical operations. Staphylococcus aureus is the most common cause of surgical wounds. Artemisia absinthium has been shown to bear strong antimicrobial activity, especially against Gram-positive pathogens. This study was designed to investigate the antimicrobial effects of A. absinthium against surgical wounds infected by S. aureus in a rat model. Twenty male Sprague-Dawley rats were divided randomly into two equal groups of treated and control rats. A circular incision was created on the dorsal inter-scapular region of each rat. After skin wounding, rats were inoculated locally with 1×10(4) CFU of S. aureus at sites of skin wounds. The extract was applied topically twice a day throughout the experiment. Animals of the control group were left untreated. Results have revealed that topical application of A. absinthium extract on the infected wound sites produced significant antibacterial activity against S. aureus.

Cutaneous distribution and localization of Cercopithifilaria sp. microfilariae in dogs

The aim of this study was to investigate the anatomical distribution of microfilariae of a recently described Cercopithifilaria sp. and the relationship with the preferred attachment sites of its vector, the brown dog tick Rhipicephalus sanguineus. Skin samples from 20 dogs were collected from eight anatomical sites and soaked twice in saline solution at 37°C. All samples were also molecularly processed for the specific amplification of partial cytochrome c oxidase 1 gene. Microfilariae were unevenly distributed on the body, with higher frequencies on interscapular region (n=13; 68.4%) and on the head (n=9; 47.4%). Larval abundance in dogs was positively correlated with the number of positive anatomical sites with a higher percentage of skin samples scoring positive at the microscopic examination of the first sediment (n=47; 30.9%) than of the second (n=8; 5.3%). Histological examination revealed that microfilariae were scattered in the dermis, in association with inflammatory cells. Molecular analysis of skin samples showed a lower frequency of positive sites (n=37; 24.3%) when compared to the microscopic examination (n=53; 34.9%) with five haplotypes sequenced. The results here presented suggested a close co-evolution of this filarioid with its vector.

Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens

The objective was to evaluate ovarian activity reversibility in domestic queens after short-term contraceptive treatment with deslorelin acetate. Ten mature queens were used. In all queens, the estrous cycle was evaluated every 72 h by vaginal cytology (VC) and behavior assessments. When queens had VC characteristic of interestrus or diestrus, one deslorelin acetate implant (4.7 mg) was placed in the subcutaneous tissue of the interscapular region (day of insertion = Day 0). Thereafter, VC was performed every 48 h and on Day 90, implants were removed. At Day 100, estrus and ovulation were induced with 100 IU eCG (im), followed by 100 IU hCG (im), 84 h later (Day 103.5). Queens were ovariohysterectomized on Day 106. Corpora lutea (CL) were counted, oviducts were flushed, and oocytes were identified, isolated and stained to assess viability. In all queens, blood samples for plasma progesterone concentrations were collected once a week, from Days −21 to 106. After deslorelin acetate application, four queens had VC and behavior typical of estrus, and one ovulated. Furthermore, ovulation occurred in three queens that did not have VC or behavior consistent with estrus. After the initial ovarian stimulation, all females had anestrous VC during the deslorelin treatment period. Implants were readily removed. Following implant removal, all females responded to treatments to induce estrus and ovulation. There were (mean ± SEM) 13.1 ± 5.5 CL and 8.1 ± 5.5 oocytes per queen; the oocyte recovery rate was 56.8 ± 25.4% and all recovered oocytes were viable. We concluded that deslorelin acetate can be used as a reversible short-term contraceptive in domestic cats, because estrus and ovulation were successfully induced following implant removal.

Abstract 5273: XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy, target validation and predictive biomarker discovery studies

Abstract Despite considerable efforts in understanding the biology and genetics of cancer, most currently available treatments fail to achieve tumor eradication in the majority of patients. Key to more effective therapies is adequate disease classification and subsequent patient stratification. In addition, it is important to understand the mechanisms of drug-response or resistance and identify novel targets amenable to therapeutic intervention. It is increasingly recognized that at the preclinical stage, testing therapeutic strategies and validating target relevance in more predictive models closely mimicking clinical disease such as patient derived xenografts (PDXs), may translate into improved clinical efficacy and lower rate of drug attrition. XenTech collection of over 120 runing PDX models is one of the largest in the world. PDX models were established by grafting post-surgery human tumor fragments in the interscapular region of immunodeficient mice. These deeply characterized PDX models can be used for in vivo preclinical assays. Such preclinical platform is a reliable surrogate of patient cohorts and can address several aims: 1. Evaluate tumor response to treatment. PDXs can be subjected to parallel evaluation of tumor response to various treatment protocols. Drug-response profile is linked to tumor histotype and molecular features in order to identify predictive markers of drug response to assist treatment choice. 2. Assess treatment-driven tumor eradication. The ability of a treatment to induce complete tumor response is assessed by monitoring tumor regression over a long period. Most tumors, despite complete macroscopic regression, are still present as latent microscopic nodular islands that may give rise to tumor recurrence. Molecular characterization of tumor foci responsible for tumor relapse may be performed to identify genes/pathways involved in residual tumor cell survival, which may provide new diagnostic and/or therapeutic targets for designing novel adjuvant treatment strategies. 3. Development of bioluminescent metastatic models to study the mechanisms of tumor invasion and to test anti-metastatic therapy. 4. Non-invasive molecular imaging technology to monitor tumor metabolism, vascularization and apoptosis. 5. Constitution of preclinical panels of rare malignancies to obtain phase II-like tumor cohorts. Development of new therapies for rare tumors is rendered difficult by the unavailability of patient cohorts wide enough to set up robust clinical trials. To assist the clinical need, these panels would allow the evaluation of new and more efficient therapies. We describe here in detail our PDX collection and illustrate how it represents a powerful tool to identify preferential therapeutic options for patients by exploring and improving anti-cancer therapeutic strategies. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 5273. doi:1538-7445.AM2012-5273

Feline vaccination practices and protocols used by veterinarians in the United Kingdom

Vaccination is an important aspect of disease control in the feline population, as it prevents disease or reduces its severity in individual cats. However the types of antigens that should be administered to cats, the frequency of administration of certain antigens and the anatomical location at which vaccines should be administered are controversial. Various groups have developed guidelines to help veterinarians decide vaccine protocols for cats in their care. The aim of this study was to survey veterinarians in the United Kingdom about the vaccination protocols used in 2007-2008. A questionnaire about aspects of feline vaccination was distributed to a 431 veterinary practices taking part in a case-control study of feline injection site sarcomas. A response rate of 72% was achieved. The majority of veterinarians who responded administered the commonly used antigens annually (84-96% of practices). Most of the veterinarians administered most vaccines in the interscapular region (90-96% of practices depending on the antigen). The vaccination practices of the veterinarians were not consistent with the published vaccination guidelines at that time.

Oral administration of interferon‐τ reduces adiposity in Zucker diabetic fatty rats

The Zucker diabetic fatty (ZDF) rat spontaneously develops type‐2 diabetes at 7 to 8 weeks of age. This study tested the hypothesis that oral administration of Interferon‐ô (IFNT) reduces obesity and delay the onset of diabetes in ZDF rats. Beginning at 4 weeks of age, 18 male ZDF rats were fed a Purina 5008 diet and received drinking water containing 0, 330 and 660 ng IFNT/100 mL (n=6/group), providing 0, 4 and 8 μg IFNT/kg BW per day. At 12 weeks of age, rats were euthanized to obtain tissues. Water or food intake did not differ (P > 0.05) among the three groups of rats. Compared to the control group, oral administration of 8 μg IFNT/kg BW per day reduced (P < 0.05) the body weight of the rats by 6.2%, the onset of diabetes by 8.5 days, concentrations of branched‐chain amino acids by 28%, and white adipose tissue by 40%, while increasing (P < 0.05) brown adipose tissue (BAT) in the interscapular region by 46%. Oral administration of 8 μg IFNT/kg BW per day enhanced (P < 0.05): 1) glucose oxidation in the liver, BAT, and white adipose tissue; 2) oleate oxidation in the liver, gastrocnemius muscle and BAT; and 3) leucine transamination in skeletal muscle. None of the measured variables differed (P > 0.05) between the rats receiving oral administration of 0 and 4 μg IFNT/kg BW per day. Our results indicate that IFNT at 8 μg IFNT/kg BW per day reduced obesity and improved the metabolic profile in ZDF rats. (Supported by AHA and NIH grants)

Is There a Difference between the Effects of One-Point and Three-Point Indirect Moxibustion Stimulation on Skin Temperature Changes of the Posterior Trunk Surface?

To determine whether any difference exists in responses to indirect moxibustion relative to thermal stimulation sites. Twenty one healthy men of mean±SD age 22.5±6.1 years were randomly divided into two groups, one receiving a single moxibustion stimulation in three locations (the three-point stimulation group, n=10 participants) and the other receiving three stimulations in one location (the one-point stimulation group, n=11 participants). The thermal stimulation sites were GV14, GV9 and GV4 acupuncture points. A thermograph was used to obtain the skin temperature on the posterior trunks of the participants. To analyse skin temperature, four arbitrary frames (the scapular, interscapular, lumbar and vertebral regions) were made on the posterior trunk. An increase in skin temperature on the posterior trunk was observed following both one- and three-point moxibustion administrations. The skin temperature of the lumbar region showed a significant increase after three-point stimulation compared with single-point stimulation (p=0.011). There was also a significant increase in skin temperature of the spinal region after three-point stimulation compared with one-point stimulation (p=0.046). Administration of single moxibustion doses on the GV14, GV9 and GV4 points produces greater changes in skin temperature than three applications of moxibustion to the GV14 point only.

Evaluation of a 125I-labelled benzazepinone derived voltage-gated sodium channel blocker for imaging with SPECT

Voltage-gated sodium channels (VGSCs) are a family of transmembrane proteins that mediate fast neurotransmission, and are integral to sustain physiological conditions and higher cognitive functions. Imaging of VGSCs in vivo holds promise as a tool to elucidate operational functions in the brain and to aid the treatment of a wide range of neurological diseases. To assess the suitability of 1-benzazepin-2-one derived VGSC blockers for imaging, we have prepared a (125)I-labelled analogue of BNZA and evaluated the tracer in vivo. In an automated patch-clamp assay, a diastereomeric mixture of the non-radioactive compound blocked the Na(v)1.2 and Na(v)1.7 VGSC isoforms with IC(50) values of 4.1 ± 1.5 μM and 0.25 ± 0.07 μM, respectively. [(3)H]BTX displacement studies revealed a three-fold difference in affinity between the two diastereomers. Iodo-destannylation of a tin precursor with iodine-125 afforded the two diastereomerically pure tracers, which were used to assess binding to VGSCs in vivo by comparing their tissue distributions in mice. Whilst the results point to a lack of VGSC binding in vivo, SPECT imaging revealed highly localized uptake in the interscapular region, an area typically associated with brown adipose tissue, which in addition to high metabolic stability of the iodinated tracer, demonstrate the potential of 1-benzazepin-2-ones for in vivo imaging.

Brown adipose tissue: distribution and influencing factors on FDG PET/CT scan

Brown adipose tissue (BAT) functions as a thermogenic organ by producing heat to maintain body temperature in many mammals, especially in the young. BAT is generally found in deep cervical, supraclavicular, interscapular, and paravertebral regions, as well as areas near large vessels. If not recognized, BAT activity can considerably interfere with 18F-fluorodeoxyglucose position emission tomography (PET)/computed tomography (CT) image interpretation. BAT activation can be influenced by several factors and reduced by different methods. In this paper, we review BAT distribution and factors influencing BAT activity on FDG PET/CT scan. The purpose of this review is to enhance the recognition of pediatric-related physician of BAT on FDG PET/CT scan.

Disección aórtica: 2 casos de presentación atípica

Aortic dissection is an uncommon disease with high mortality. The typical clinical picture is characterised by sudden pain in the retrosternal or interscapular region radiating to the back and abdomen. There can be several signs, depending on the arterial branches involved (stroke, renal or mesenteric ischaemia), and even the absence of pain.Two cases with unusual presentations are discussed; one with sudden paresis and ischaemia of both legs with involvement of spinal and iliac branches, and the other began as a syncope and right hemiparesis with carotid involvement.

Urocortins Improve Dystrophic Skeletal Muscle Structure and Function through Both PKA- and Epac-Dependent Pathways

In Duchenne muscular dystrophy, the absence of dystrophin causes progressive muscle wasting and premature death. Excessive calcium influx is thought to initiate the pathogenic cascade, resulting in muscle cell death. Urocortins (Ucns) have protected muscle in several experimental paradigms. Herein, we demonstrate that daily s.c. injections of either Ucn 1 or Ucn 2 to 3-week-old dystrophic mdx(5Cv) mice for 2 weeks increased skeletal muscle mass and normalized plasma creatine kinase activity. Histological examination showed that Ucns remarkably reduced necrosis in the diaphragm and slow- and fast-twitch muscles. Ucns improved muscle resistance to mechanical stress provoked by repetitive tetanizations. Ucn 2 treatment resulted in faster kinetics of contraction and relaxation and a rightward shift of the force-frequency curve, suggesting improved calcium homeostasis. Ucn 2 decreased calcium influx into freshly isolated dystrophic muscles. Pharmacological manipulation demonstrated that the mechanism involved the corticotropin-releasing factor type 2 receptor, cAMP elevation, and activation of both protein kinase A and the cAMP-binding protein Epac. Moreover, both STIM1, the calcium sensor that initiates the assembly of store-operated channels, and the calcium-independent phospholipase A(2) that activates these channels were reduced in dystrophic muscle by Ucn 2. Altogether, our results demonstrate the high potency of Ucns for improving dystrophic muscle structure and function, suggesting that these peptides may be considered for treatment of Duchenne muscular dystrophy.

Orexin microinjection in the medullary raphe increases heart rate and arterial pressure but does not reduce tail skin blood flow in the awake rat

The rostral medullary raphe region is an important target of hypothalamic orexin neurons; however, little is known of the effect of orexin in this key autonomic and somatic premotor region. Here we tested the effect of orexin-A (3 and 30 pmol) microinjected in the medullary raphe, on heart rate (HR), mean arterial pressure (MAP), tail skin blood flow, body temperature, and behavior in freely moving, awake rats. HR, MAP, and body activity were recorded by radio-telemetry. Changes in tail skin blood flow and body temperature, as well as potential interscapular brown adipose tissue thermogenesis were recorded indirectly by infrared thermography of the skin of the tail, lumbosacral back, and interscapular back areas, respectively. Compared with saline, orexin-A (30 pmol) evoked significant and long lasting increases in HR (+99 bpm), MAP (+11 mmHg), and body activity (grooming, not locomotor activity). However, it did not reduce tail skin blood flow more than saline, and there was no significant increase in body temperature. A small, though significant, thermogenic effect was observed in the interscapular region, but this effect is more likely to have originated from activity in neck and shoulder muscles than brown adipose tissue. Thus, orexin projections to the rostral medullary raphe can mediate significant cardiovascular changes, but does not seem to affect tail skin vasomotor tone or brown adipose tissue in the awake rat. This important brainstem relay may contribute to the cardiovascular changes evoked by arousal and various forms of stress that are associated with activation of orexin neurons.

Difficultés d’intégration sociale au cours de la maladie de Darier en Afrique : trois cas

Darier's disease is a rare disease. Multiple clinical forms have been observed, but the psychosocial aspects in Africa are rarely described. We report three cases involving difficulties regarding social integration. Case no. 1: a 19-year-old woman consulted for hyperchromic, greyish, keratotic papules, grouped in small plaques scattered all over the body. She had trouble finding a husband and was rejected by her peers. Case no. 2: a 20-year-old woman presented generalized keratotic, vegetative lesions. She was rejected by her husband because of the lesions. Like patient no. 1, she was unable to purchase her prescribed treatment. Case no. 3: a 33-year-old blacksmith presented Darier's disease with lesions on the interscapular region and chest. He was epileptic and depressive and was partly rejected by his family. Darier's disease, diagnosed on the basis of anatomoclinical factors, had a major impact on the social integration of all three patients. These generalised disfiguring forms of the disease adversely affect the quality of life and their association with neuropsychiatric disorders is another major handicap. Difficulties concerning social integration and therapeutic problems must be considered in the management of Darier's disease in Africa.

Abstract B11: A panel of patient-derived xenografts for preclinical efficacy studies in various breast cancer molecular subtypes.

Abstract Background: Breast cancer (BC) is a clinically and molecularly heterogeneous disease where tailoring therapy to specific tumor subtypes is a focus of today's clinical developments. The availability of relevant preclinical models replicating BC's molecular diversity is therefore of crucial importance for the success of IND translation to the clinic. We present a collection of 34 BC tumor xenografts established directly onto Nude mice from patients' tumor sample for in vivo preclinical evaluation of drug efficacy. These in vivo models reproduce accurately the molecular and drug response profile of human tumors, and provide an invaluable tool for translational research. Methods: Post-surgery tumor specimens were transplanted either by grafting tumor fragments in the interscapular region of nude mice or by injection of tumor cells into the fat pad of NOD-Scid mice; this fat pad being previously cleared of murine gland and humanized by injection of normal human fibroblasts. BC xenografts were amplified by serial transplantation, and tissue samples were retained at each passage for comparison with the patient's tumor. Molecular analyses included gene expression (Affymetrix® Hu133), gene copy number (Affymetrix® Human Genome 6.0) and IHC markers on FFPE samples. In vivo drug efficacy assays were performed with standards of care as single agent or in combinations. Results: Among the 34 BC xenografts, 32 are ductal carcinoma, 2 lobular carcinomas and among them 4 are inflammatory breast cancers. Twenty two tumors express low or no hormone receptors and do not overexpress ERBB2, they can be considered as triple-negative tumors. Five tumors overexpress ERBB2, one of which also express hormonal receptors. Seven tumors express both estrogen and progesterone receptors and do not overexpress ERBB2, they can thus be considered as luminal-like tumors. Hence, this panel mostly reflects the molecular heterogeneity of breast cancer. To confirm this further, tumorgraft gene expression data were crossed with patient datasets, and hierarchical clustering was performed by using patient-derived gene lists that stratify breast cancer according to molecular phenotype. This analysis showed that breast cancer tumorgrafts evenly distributed among human samples and properly classified within the molecular subtypes corresponding to their histopathological features. A panel of standard chemotherapies was tested in vivo (adriamycin/cyclophosphamide, capecitabine, docetaxel, trastuzumab and lapatinib) to generate a profile of drug sensitivity for each model. Conclusion: This panel of 34 BC xenografts allows preclinical assays in clinically relevant models encompassing the molecular diversity of BC. Its broadness and extensive molecular characterization will also be useful to identify molecular determinants of drug response. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2011 Nov 12-16; San Francisco, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2011;10(11 Suppl):Abstract nr B11.

Effect of calorie restriction and refeeding on skin wound healing in the rat

Calorie restriction (CR) is a reliable anti-aging intervention that attenuates the onset of a number of age-related diseases, reduces oxidative damage, and maintains function during aging. In the current study, we assessed the effects of CR and other feeding regimens on wound healing in 7-month-old Fischer-344 rats from a larger cohort of rats that had been fed either ad libitum (AL) or 40% calorie restricted based on AL consumption. Rats were assigned to one of three diet groups that received three skin punch wounds along the dorsal interscapular region (12-mm diameter near the front limbs) of the back as follows: (1) CR (n = 8) were wounded and maintained on CR until they healed, (2) AL (n = 5) were wounded and maintained on AL until wound closure was completed, and (3) CR rats were refed (RF, n = 9) AL for 48 h prior to wounding and maintained on AL until they healed. We observed that young rats on CR healed more slowly while CR rats refed for 48 h prior to wounding healed as fast as AL fed rats, similar to a study reported in aged CR and RF mice (Reed et al. 1996). Our data suggest that CR subjects, regardless of age, fail to heal well and that provision of increased nutrition to CR subjects prior to wounding enhances the healing process.

Effects of the GnRH analogue deslorelin implants on reproduction in female domestic cats

The aim of the present study was to investigate the safety and efficacy of deslorelin, a GnRH agonist, implants in suppressing estrus behavior and matings in a controlled ambient environment in feline queens in the presence of a tomcat. Local and utero-ovarian side effects of deslorelin implants were also investigated. The queens were housed in groups and assigned to one of three treatments: group 1 received 9.5 mg deslorelin implants (N = 14), group 2 received 5 mg megestrol acetate tablets and 9.5 mg deslorelin implants (N = 7), and group 3 were given placebo implants (N = 7). All implants were placed subcutaneously cranial to the interscapular region under xylazine hydrochloride sedation. Ovarian activity was monitored by fecal estradiol (E 2) analyses. The animals were observed daily and checked individually at three-day intervals for behavioral signs of estrus. After 18.5 mo of trial, queens were ovariohysterectomized, and ovaries and uteri were weighed and evaluated histologically. E 2 levels were significantly lower in group 1 and 2 than in group 3 with an average of 128.48 ± 19.97 ng/g, 90.44 ± 7.16 ng/g and 283.26 ± 39.21 ng/g, respectively, excepting the first week of treatment. After inserting implants an initial estrus-like increase in fecal E 2 concentrations occurred in all treated queens except one female in group 2. Ovarian and uterine weights were significantly different among the groups (P < 0.01), and were lowest in groups 1 and 2. Primordial and primary follicle numbers were significantly higher in groups 1 and 2 than in group 3 (P < 0.001). Endometrial gland, antral follicle, and corpus luteum (CL) numbers were highest in group 3 (P < 0.01, 0.001, and 0.001, respectively) compared with groups 1 and 2. Deslorelin implants successfully suppressed estrus behavior and E 2 secretion in queens for 18.5 mo of the study period. Further investigations are needed to demonstrate the effects of GnRH agonists on ovarian interstitial tissue.

Thalidomide delayed the ability of 4T1 cells to amass into tumors in Balb/c mice

Thalidomide (Thal) can suppress the growth of established, as well as explanted tumors in mice. We wanted to determine if it could suppress the ability of tumor cells to assemble and establish a primary tumor at the injection site. Using the mouse 4T1 mammary tumor model, we fed Thal to mice for 4 days, then injected 105 4T1 cells into the interscapular region of Balb/c mice. After 20 days on treatment with Thal, all seven control mice, fed with meal had tumors ranging from 3 to 93 mm3 (median 20). Two of the eight mice fed with meal + Thal had no tumors, and the remaining mice had tumors ranging from 2 to 22 mm3 (median 5). The median volume of the tumors in the control group was significantly more than that of mice treated with Thal (p = 0.03, Mann–Whitney test). In vitro treatment of the 4T1cells with Thal did not inhibit their ability to proliferate, to adhere to plastic, or to bind to Concanavalin-A. Thal caused a marked reduction in the ability of the 4T1 cells to assemble into palpable tumors.

Development of an injection site sarcoma shortly after meloxicam injection in an unvaccinated cat

A single dose of a rapidly-absorbed non-steroidal anti-inflammatory drug (NSAID) was injected into the subcutaneous tissue of the interscapular region of a 12.5-year-old cat. A mild swelling was noticed at the injection site 6 weeks later. This progressed into a 5 cm diameter mass which was removed 6 months after the injection had been given. An injection site sarcoma (ISS) was diagnosed histologically. As the cat had not been vaccinated for at least 12 years, the previous NSAID injection was considered to be a possible cause of the ISS. Inflammation is thought to be important in the development of ISS. If injection of a rapidly-absorbed NSAID can stimulate sufficient inflammation to promote the development of an ISS, other non-vaccine injections may also have the potential to influence ISS development. This suggests that injection of both vaccines and non-vaccine medications should be minimised to reduce the risk of ISS development.

Is There a Difference between the Effects of Single and Triple Indirect Moxibustion Stimulations on Skin Temperature Changes of the Posterior Trunk Surface?

To determine whether any difference exists in responses to indirect moxibustion (IM) relative to thermal stimulation duration. In experiment 1, 9 subjects attended two experimental sessions consisting of single stimulation with IM or triple stimulation with IM, using a crossover design. A K-type thermocouple temperature probe was fixed on the skin surface at the GV14 acupuncture point. IM stimulation was administered to the top of the probe in order to measure the temperature curve. In addition, each subject evaluated his or her subjective feeling of heat on a visual analogue scale after each stimulation. Experiment 2 was conducted on 42 participants, divided into three groups according to the envelope allocation method: single stimulation with IM (n=20), triple stimulation with IM (n=11) and a control group (n=11). A thermograph was used to obtain the skin temperature on the posterior trunk of the participant. To analyse skin temperature, four arbitrary frames (the scapular, interscapular, lumbar and vertebral regions) were made on the posterior trunk. In experiment 1, no significant difference in maximum temperature was found in IM and subjective feeling of heat intensity between single and triple stimulation with IM. In experiment 2, increases in skin temperature occurred on the posterior trunk, but no differences in skin temperature occurred between the groups receiving single and triple stimulation with IM. No difference exists in the skin temperature response to moxibustion between the single and triple stimulation with IM.

Evidence for critical period in development of cutaneous innervation: A study in nude mice

Cutaneous sensory structures are important sources for guidance cues and neurotrophic support for the sensory nerves innervating them. Spontaneous mutation of the hair follicles in the skin of nude mice provides an excellent model to test the role played by sensory structures in the development of their sensory innervation. The innervation of the skin in normal and nude mice was compared using several pan neuronal markers and keratin 14 antibodies. The pattern of innervation of the skin was disrupted in nude mice; the normal arrangement of three horizontal nerve plexuses was lost and replaced by random nerve fibers. Also, the density of sensory innervation in nude skin was decreased compared to normal skin. The rudimentary follicles in nude skin did not carry lanceolate endings in the isthmus region or Merkel endings in the rete ridge. To determine if a normal target can reverse these innervation errors, normal skin was grafted onto the dorsal interscapular region of nude skin. Analysis of the innervation pattern in grafted skin revealed that the abnormal pattern persisted. We conclude that hair follicles are required for patterning cutaneous sensory nerves and that the innervation defects cannot be reversed upon exposure to a normal target later in development. The latter finding suggests that a critical window exists for correct pattern formation in the cutaneous sensory nerves.